Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06025357 · ClinicalTrials.gov registry record · NA
Effects of L-citrulline Supplementation on Vascular Function in Metabolic Syndrome
A NA study, sponsored by Texas Tech University.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT06025357 is a NA study that has completed, run by Texas Tech University. The registered enrollment target is 24 participants.
The verdict
NCT06025357, a NA study, has completed, sponsored by Texas Tech University.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
The objective of this project is to provide evidence that L-Citrulline (CIT) supplementation can improve vascular function in the fasted and acute hyperglycemia conditions in middle-aged and older women with metabolic syndrome.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT L-Citrulline supplementation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2023-01-01 |
| Est. Completion | 2024-08-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06025357
The ClinicalTrials.gov registry entry for NCT06025357 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Texas Tech University, which has 69 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT06025357 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06025357 about?
NCT06025357 is a clinical study titled "Effects of L-citrulline Supplementation on Vascular Function in Metabolic Syndrome". The objective of this project is to provide evidence that L-Citrulline (CIT) supplementation can improve vascular function in the fasted and acute hyperglycemia conditions in middle-aged and older women with metabolic syndrome.
What is the current status of trial NCT06025357?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2023-01-01. Estimated completion is 2024-08-01.
What interventions are being tested in trial NCT06025357?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), L-Citrulline supplementation (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06025357?
This trial is sponsored by Texas Tech University, which has 69 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.